DROPERIDOL Drug Patent Profile
Which patents cover Droperidol, and what generic alternatives are available?
Droperidol is a drug marketed by Abraxis Pharm, Am Regent, Astrazeneca, Hikma, Hospira, Igi Labs Inc, Luitpold, Smith And Nephew, Solopak, and Watson Labs. and is included in eighteen NDAs.
The generic ingredient in DROPERIDOL is droperidol. There is one drug master file entry for this compound. Two suppliers are listed for this compound. Additional details are available on the droperidol profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Droperidol
A generic version of DROPERIDOL was approved as droperidol by AM REGENT on October 24th, 1988.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for DROPERIDOL?
- What are the global sales for DROPERIDOL?
- What is Average Wholesale Price for DROPERIDOL?
Summary for DROPERIDOL
| US Patents: | 0 |
| Applicants: | 10 |
| NDAs: | 18 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Clinical Trials: | 46 |
| Patent Applications: | 4,670 |
| DailyMed Link: | DROPERIDOL at DailyMed |
Recent Clinical Trials for DROPERIDOL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Stanford University | EARLY_PHASE1 |
| Universitas Padjadjaran | PHASE2 |
| University of Thessaly | PHASE4 |
Pharmacology for DROPERIDOL
| Drug Class | Dopamine-2 Receptor Antagonist |
| Mechanism of Action | Dopamine D2 Antagonists |
Medical Subject Heading (MeSH) Categories for DROPERIDOL
Anatomical Therapeutic Chemical (ATC) Classes for DROPERIDOL
US Patents and Regulatory Information for DROPERIDOL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abraxis Pharm | DROPERIDOL | droperidol | INJECTABLE;INJECTION | 070992-001 | Nov 17, 1986 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Watson Labs | DROPERIDOL | droperidol | INJECTABLE;INJECTION | 073523-001 | Nov 27, 1991 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Hospira | DROPERIDOL | droperidol | INJECTABLE;INJECTION | 071981-001 | Feb 29, 1988 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Astrazeneca | DROPERIDOL | droperidol | INJECTABLE;INJECTION | 072018-001 | Oct 20, 1988 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
